A Phase II Study of Irinotecan, 5-Fluorouracil and Leucovorin for Treatment in Patients with Previously Untreated Advanced Colorectal Cancer

PURPOSE: We prospectively conducted a non-randomized phase II trial to evaluate the efficacy and safety of combination irinotecan, leucovorin (LV) and 5-fluorouracil (FU) as a first-line regimen for treating patients with previously untreated advanced colorectal cancer (CRC). MATERIALS AND METHODS:...

詳細記述

保存先:
書誌詳細
主要な著者: Bae, Sang-Byung, Lee, Nam-Su, Kim, Han-Jo, Kim, Kyoung-Ha, Kim, Hyun-Jung, Kim, Chan-Kyu, Lee, Kyu-Taeg, Park, Sung-Kyu, Won, Jong-Ho, Hong, Dae-Sik, Park, Hee-Sook
フォーマット: Artigo
言語:Inglês
出版事項: Korean Cancer Association 2006
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2741663/
https://ncbi.nlm.nih.gov/pubmed/19771263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2006.38.2.72
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料